T1	disease_or_phenotypic_feature 0 6	Asthma
T2	chemical 11 23	sex hormones
T3	chemical 25 30	Fatty
T4	chemical 25 36	Fatty acids
T5	chemical 59 72	carbon-carbon
T6	chemical 102 127	conjugated linoleic acids
T7	disease_or_phenotypic_feature 205 213	diabetes
T8	disease_or_phenotypic_feature 215 221	cancer
T9	disease_or_phenotypic_feature 227 242	atherosclerosis
T10	disease_or_phenotypic_feature 261 278	Liddle's syndrome
T11	disease_or_phenotypic_feature 296 307	hypokalemic
T12	disease_or_phenotypic_feature 308 320	hypertension
T13	chemical 358 364	sodium
T14	disease_or_phenotypic_feature 358 364	sodium
T15	chemical 437 446	potassium
T16	disease_or_phenotypic_feature 486 493	sarcoma
T17	chemical 506 515	pazopanib
T18	chemical 520 529	valproate
T19	chemical 613 617	drug
T20	chemical 632 642	Mefloquine
T21	disease_or_phenotypic_feature 651 668	grand mal seizure
T22	disease_or_phenotypic_feature 676 683	malaria
T23	disease_or_phenotypic_feature 753 779	small bowel adenocarcinoma
T24	chemical 874 893	glucose-transporter
T25	disease_or_phenotypic_feature 956 962	cancer
T26	chemical 978 981	CIT
T27	chemical 1000 1007	antigen
T28	chemical 1041 1044	DCs
T29	chemical 1080 1088	antigens
T30	chemical 1197 1201	drug
T31	disease_or_phenotypic_feature 1264 1272	seizures
T32	chemical 1290 1303	aminophylline
T33	chemical 1309 1320	pilocarpine
T34	disease_or_phenotypic_feature 1329 1337	seizures
T35	disease_or_phenotypic_feature 1386 1393	obesity
T36	disease_or_phenotypic_feature 1394 1406	hypertension
T37	chemical 1408 1414	sodium
T38	disease_or_phenotypic_feature 1485 1502	visual impairment
T39	disease_or_phenotypic_feature 1513 1533	cognitive impairment
T40	chemical 1573 1577	urea
T41	chemical 1578 1586	nitrogen
T42	chemical 1593 1603	creatinine
T43	chemical 1631 1638	hormone
T44	chemical 1737 1744	hormone
T45	disease_or_phenotypic_feature 1745 1754	dependent
T46	disease_or_phenotypic_feature 1763 1782	Laryngeal carcinoma
T47	chemical 1799 1810	sex hormone
T48	disease_or_phenotypic_feature 1811 1820	dependent
T49	chemical 1858 1861	NPY
T50	chemical 1862 1882	receptor antagonists
T51	disease_or_phenotypic_feature 1901 1908	obesity
T52	disease_or_phenotypic_feature 1913 1937	cardiovascular disorders
T53	disease_or_phenotypic_feature 1950 1956	Asthma
T54	chemical 1997 2003	oxygen
T55	chemical 2059 2073	growth hormone
T56	chemical 2082 2089	glucose
T57	disease_or_phenotypic_feature 2108 2115	obesity
T58	disease_or_phenotypic_feature 2154 2157	ICC
T59	chemical 2309 2312	DDD
T60	chemical 2362 2368	saline
T61	disease_or_phenotypic_feature 2424 2431	hepatic
T62	disease_or_phenotypic_feature 2439 2454	Medulloblastoma
T63	chemical 2474 2481	biology
T64	chemical 2546 2554	Graphite
T65	disease_or_phenotypic_feature 2566 2571	K-Ion
T66	chemical 2566 2571	K-Ion
T67	disease_or_phenotypic_feature 2669 2681	mesothelioma
T68	chemical 2711 2722	nimotuzumab
T69	chemical 2776 2780	drug
R1	treats Arg1:T6 Arg2:T7	
T70	missed_chemical 129 133	CLAs
R2	treats Arg1:T70 Arg2:T7	
R3	treats Arg1:T6 Arg2:T8	
R4	treats Arg1:T70 Arg2:T8	
R5	treats Arg1:T6 Arg2:T9	
R6	treats Arg1:T70 Arg2:T9	
T71	corrected_chemical 25 85	Fatty acids containing conjugated carbon-carbon double bonds
R7	treats Arg1:T71 Arg2:T7	
R8	treats Arg1:T71 Arg2:T8	
R9	treats Arg1:T71 Arg2:T9	
T72	corrected_disease_or_phenotypic_feature 486 500	sarcoma tumors
R10	treats Arg1:T17 Arg2:T72	
R11	treats Arg1:T18 Arg2:T72	
R12	causes_or_contributes_to Arg1:T20 Arg2:T21	
T73	missed_chemical 1243 1255	pentetrazole
R13	causes_or_contributes_to Arg1:T73 Arg2:T31	
R14	causes_or_contributes_to Arg1:T32 Arg2:T34	
R15	causes_or_contributes_to Arg1:T33 Arg2:T34	
R16	causes_or_contributes_to Arg1:T47 Arg2:T46	
T74	corrected_chemical 1858 1882	NPY receptor antagonists
R17	treats Arg1:T74 Arg2:T51	
R18	treats Arg1:T74 Arg2:T52	
R19	treats Arg1:T68 Arg2:T67	
